Cases 61 - 70 of 242
ViiV Healthcare Company et al v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv01671
Plaintiff:
ViiV Healthcare Company , Shionogi & Co., Ltd. and ViiV Healthcare UK (No. 3) Limited
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL.
as 2:2017cv11635
Petitioner:
BAKER BOTTS LLP and PHV STEPHEN M. HASH
Defendant:
LUPIN LTD, MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LIMITED and others
Plaintiff:
HORIZON PHARMA, INC and POZEN INC.
Cause Of Action: Motion to Quash
Delcor Asset Corporation et al v. Glenmark Pharmaceuticals Limited et al
as 1:2017cv01653
Plaintiff:
Delcor Asset Corporation and Mylan Pharmaceuticals Inc.
Defendant:
Glenmark Pharmaceuticals Limited , Glenmark Pharmaceuticals Inc., USA and Stiefel West Coast, LLC
Cause Of Action: 35 U.S.C. § 271
SANOFI-AVENTIS U.S. LLC et al v. MYLAN N.V. et al
as 2:2017cv09105
Plaintiff:
SANOFI-AVENTIS U.S. LLC , SANOFI-AVENTIS DEUTSCHLAND GMBH and SANOFI WINTHROP INDUSTRIE
Defendant:
MYLAN N.V. , MYLAN GMBH , MYLAN INC. and others
Cause Of Action: 35 U.S.C. § 271
SANOFI-AVENTIS U.S. LLC et al v. MYLAN N.V. et al
as 3:2017cv09105
Plaintiff:
SANOFI-AVENTIS U.S. LLC , SANOFI-AVENTIS DEUTSCHLAND GMBH and SANOFI WINTHROP INDUSTRIE
Defendant:
MYLAN N.V., MYLAN GMBH, MYLAN INC. and others
Cause Of Action: 35 U.S.C. § 271
AMGEN INC et al v. MYLAN INC. et al
as 2:2017cv01235
Defendant:
MYLAN GMBH, MYLAN PHARMACEUTICALS INC, MYLAN INC. and others
Plaintiff:
AMGEN INC and AMGEN MANUFACTURING LIMITED
Petitioner:
HOSPIRA, INC.
Cause Of Action: 35 U.S.C. § 271
Delcor Asset Corporation et al v. Taro Pharmaceutical Industries, Ltd. et al
as 1:2017cv00970
Plaintiff:
Delcor Asset Corporation and Mylan Pharmaceuticals Inc.
Defendant:
Taro Pharmaceutical Industries, Ltd. , Taro Pharmaceuticals U.S.A., Inc. and Stiefel West Coast, LLC
Cause Of Action: 35 U.S.C. § 145
Bayer Intellectual Property GmbH et al v. Mylan Pharmaceuticals Inc.
as 1:2017cv00584
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. HETERO LABS LIMITED et al
as 2:2017cv03387
Plaintiff:
CELGENE CORPORATION
Defendant:
HETERO LABS LIMITED, HETERO LABS LIMITED UNIT-V, HETERO DRUGS LIMITED and others
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
as 1:2017cv00389
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Pharmaceuticals Inc.
Counter_defendant:
Novartis AG and Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
